Skip to content

Clinical trials

Completed Alzheimer Disease trials in Portugal

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Status: Completed Country / region: Portugal Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20071
20081
20101
20111
20143
20153
20191
20211
20222
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Rsocialform - Geriatria, Lda3
Boehringer Ingelheim2
H. Lundbeck A/S2
Hoffmann-La Roche2
Pfizer2
Eidos Therapeutics, a BridgeBio company1
GemVax & Kael1
GlaxoSmithKline1
Novartis Pharmaceuticals1
Novo Nordisk A/S1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease19
Dementia5
Amyloid Neuropathies, Familial3
Amyloidosis3
Cognitive Dysfunction3
Anxiety Disorders2
Neurocognitive Disorders2
Polyneuropathies2
Cardiomyopathies1
Heart Diseases1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.